Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits
Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.